Economic Costs of Diabetes in the U.S.


https://www.prnewswire.com/news-releases/amer...18564.html


Most notably, the report revealed that the economic costs of diabetes increased 26 percent from 2012 to 2017, due to both the increased prevalence of the disease and the increased cost per person living with diabetes. These costs include $237 billion in direct medical costs for diagnosed diabetes and $90 billion in reduced productivity. The largest contributors to the cost of diabetes are higher use of prescription medications beyond diabetes medications ($71.2 billion); higher use of hospital inpatient services ($69.7 billion); medications (oral agents and insulin) and supplies to directly treat diabetes ($34.6 billion), and more office visits to physicians and other health providers ($30 billion). These costs are passed on to all Americans in the form of higher medical costs, higher insurance premiums and taxes, reduced earnings, lost productivity, premature mortality, and intangible costs in the form of reduced quality of life.